<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Advances in molecular genetics are leading to changes in practice that have a direct impact on the obstetrician and gynecologist </plain></SENT>
<SENT sid="1" pm="."><plain>New techniques of prenatal screening, diagnosis, and potentially therapy are rapidly evolving </plain></SENT>
<SENT sid="2" pm="."><plain>Recent developments in cystic <z:mp ids='MP_0003045'>fibrosis</z:mp>, preimplantation genetics, <z:e sem="disease" ids="C0016667" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">fragile X syndrome</z:e>, <z:hpo ids='HP_0001067'>neurofibromatosis</z:hpo>, <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo>, and <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> are discussed </plain></SENT>
</text></document>